The Insider – Meet the Fund Manager – Joseph Constable

The Insider

Meet the Fund Manager

Joseph Constable

Portfolio Manager | HGL Limited

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

Favourite Stocks

Find out why HGL chose to invest in this financial advisory firm that dipped massively due to external factors but is now seeing an upward trend.

December 3, 2021

Learn how this insurance underwriting company executed a successful turnaround and the internal and external factors that HGL noticed as strong indicators of growth.

December 3, 2021

Hear about this childcare provider and why HGL is anticipating increased demand for its services in a ‘COVID-managed’ Australia and New Zealand.

December 3, 2021

Like these investment ideas? Join our next session to discover more like this by clicking here

Insights

Joseph talks about the reasons behind the record $500 billion inflow into equity ETFs in 2021’s first half and how rising inflation could halt this growth.

December 3, 2021

Joseph explains the key callouts HGL looks for in undervalued companies and the strategies used to unlock the value of those companies.

December 3, 2021

Joseph Constable joins us to talk about HGL’s three favourite stocks, investing in undervalued ASX-listed companies and why sticking to an investment thesis can benefit uncertain investors.

December 3, 2021

Close

Register your details



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets are the advisors assisting with the management of this offer and may receive fees depending on whether an offer is taken up by investors.

Meet the Fund Manager

Upcoming Session

Matt McNamara Board Director & CIOHorizon 3 Biotech

Meet the Manager

Get access to some of Australia’s leading fund managers who share their 3 favourite stocks, investment approach and insights on the market.

Each session includes:

  • 3 favourite stock opportunities
  • Market views for the year ahead
  • Investment strategy and approaches

This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.

Book into the next session

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

Matt McNamara

Board Director & CIO
Horizon 3 Biotech

Horizon 3 Biotech, is a biotech venture capital company seeking to capitalise on opportunities presented by emerging therapeutic and medical device companies, and the low level of investment competition in the segment. The company manages the Horizon 3 Biotech Fund, a wholesale unit trust targeting $100 million in funding and a gross return of 20% per annum using an approach that hits key inflection points faster while limiting downside and increasing the upside. Matt McNamara has more than 30 years in healthcare and medical sciences and more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.

Past Sessions

Andrew Chapman Merchant Group

Andrew Chapman, managing director of Merchant Group, has more than 20 years’ finance industry experience and market-tested knowledge on active portfolio management and risk – enabling him to offer customised investment solutions with a direct and transparent investment approach.

Samuel Berridge Perennial Partners

Samuel Berridge, portfolio manager and resources analyst, has 15 years’ experience across the mining and finance industries. He specialises in mining, mining services, oil and gas, hard commodity and small industrial sectors. In 2011, Samuel’s stock selection skills won him StarMine’s top Australian Metals and Mining Analyst Award.

Dean Fergie Cyan Investment Management

This session we were joined by Dean Fergie, head of Cyan Investment Management. In the session, Dean outlined his inclination for investing in newer businesses for a competitive advantage, and why he’s looking at the smaller end of the market to identify excess returns.

** Reach does not assume responsibility for the accuracy or completeness of any information provided, and the views expressed are not reflective of Reach Markets position. Any advice contained within this presentation is general advice and does not consider your personal circumstance, you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only. “Investing is about understanding your risk” and every time you invest in the share market there is a risk of loss.

Reach Markets

Reach Markets Pty Ltd - ABN 36 145 312 232

Is a Corporate Authorised Representative (CAR No:431191) of:

Reach Financial Group - ABN 17 090 611 680 AFSL Number 333297

Level 8, 525 Flinders Street, Melbourne Victoria

Level 7, 440 Collins Street, Melbourne 3000, Australia

Suite 803, Level 8, 14 Martin Place, Sydney 2000, Australia

T: 1300 80 57 95    

E: admin@reachmarkets.com.au

Neori theme, designed by litMotion Templates

Contact Joseph Constable Directly